个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共5条记录  
  • Determinants of brain iron in multiple sclerosis A quantitative 3T MRI study
    [作者:Khalil, M; Langkammer, C; Ropele, S; Petrovic, K; Wallner-Blazek, M; Loitfelder, M; Jehna, M; Bachmaier, G; Schmidt, R; Enzinger, C; Fuchs, S; Fazekas, F,期刊:Neurology, 页码:1691-1697 , 文章类型: Article,,卷期:2011年77-18]
  • Objectives: Abnormal high cerebral iron deposition may be implicated in chronic neurologic disorders, including multiple sclerosis (MS). R2* relaxometry has been recently validated in a postmortem study to indicate brain...
  • Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome
    [作者:Lancaster, E; Martinez-Hernandez, E; Titulaer, MJ; Boulos, M; Weaver, S; Antoine, JC; Liebers, E; Kornblum, C; Bien, CG; Honnorat, J; Wong, S; Xu, J; Contractor, A; Balice-Gordon, R; Dalmau, J,期刊:Neurology, 页码:1698-1701 , 文章类型: Article,,卷期:2011年77-18]
  • Objective: To report the metabotropic glutamate receptor 5 (mGluR5) as the autoantigen of antibodies from 2 patients with Hodgkin lymphoma (HL) and limbic encephalopathy (Ophelia syndrome).Methods: Immunohistochemistry w...
  • PRION-1 scales analysis supports use of functional outcome measures in prion disease
    [作者:Mead, S; Ranopa, M; Gopalakrishnan, GS; Thompson, AGB; Rudge, P; Wroe, S; Kennedy, A; Hudson, F; MacKay, A; Darbyshire, JH; Collinge, J; Walker, AS,期刊:Neurology, 页码:1674-1683 , 文章类型: Article,,卷期:2011年77-18]
  • Objectives: Human prion diseases are heterogeneous but invariably fatal neurodegenerative disorders with no known effective therapy. PRION-1, the largest clinical trial in prion disease to date, showed no effect of the p...